MGNX logo

MacroGenics (MGNX) Current Liabilities

Annual Current Liabilities

$56.11 M
+$7.50 M+15.42%

December 31, 2023


Summary


Performance

MGNX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMGNXbalance sheetmetrics:

Quarterly Current Liabilities

$59.31 M
+$1.40 M+2.42%

September 30, 2024


Summary


Performance

MGNX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMGNXbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

MGNX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+15.4%+5.7%
3 y3 years+10.7%-11.6%
5 y5 years-6.4%-11.6%

MGNX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-24.8%+15.4%-20.5%+31.4%
5 y5-year-24.8%+24.2%-20.5%+49.7%
alltimeall time-24.8%+131.8%-20.5%+233.1%

MacroGenics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$59.31 M(+2.4%)
Jun 2024
-
$57.91 M(+3.8%)
Mar 2024
-
$55.76 M(-0.6%)
Dec 2023
$56.11 M(+15.4%)
$56.11 M(+9.4%)
Sep 2023
-
$51.29 M(+13.6%)
Jun 2023
-
$45.16 M(-1.0%)
Mar 2023
-
$45.61 M(-6.2%)
Dec 2022
$48.61 M(-34.8%)
$48.61 M(-2.9%)
Sep 2022
-
$50.05 M(-1.6%)
Jun 2022
-
$50.88 M(-24.2%)
Mar 2022
-
$67.10 M(-10.0%)
Dec 2021
$74.58 M(+47.2%)
$74.58 M(+8.3%)
Sep 2021
-
$68.86 M(-1.5%)
Jun 2021
-
$69.92 M(+31.8%)
Mar 2021
-
$53.04 M(+4.7%)
Dec 2020
$50.67 M(+12.2%)
$50.67 M(+1.1%)
Sep 2020
-
$50.12 M(+9.2%)
Jun 2020
-
$45.89 M(+15.9%)
Mar 2020
-
$39.61 M(-12.3%)
Dec 2019
$45.17 M(-24.6%)
$45.17 M(-21.6%)
Sep 2019
-
$57.63 M(+16.4%)
Jun 2019
-
$49.53 M(-4.3%)
Mar 2019
-
$51.77 M(-13.6%)
Dec 2018
$59.94 M
$59.94 M(+24.8%)
DateAnnualQuarterly
Sep 2018
-
$48.02 M(-0.0%)
Jun 2018
-
$48.03 M(-3.9%)
Mar 2018
-
$49.96 M(+0.4%)
Dec 2017
$49.76 M(+82.2%)
$49.76 M(+53.4%)
Sep 2017
-
$32.44 M(+8.5%)
Jun 2017
-
$29.89 M(+12.6%)
Mar 2017
-
$26.55 M(-2.7%)
Dec 2016
$27.30 M(+12.8%)
$27.30 M(+23.8%)
Sep 2016
-
$22.05 M(+12.9%)
Jun 2016
-
$19.53 M(+9.7%)
Mar 2016
-
$17.81 M(-26.4%)
Dec 2015
$24.20 M(-10.7%)
$24.20 M(+8.1%)
Sep 2015
-
$22.39 M(-6.1%)
Jun 2015
-
$23.85 M(-1.2%)
Mar 2015
-
$24.13 M(-10.9%)
Dec 2014
$27.09 M(-6.0%)
$27.09 M(+4.3%)
Sep 2014
-
$25.99 M(-13.0%)
Jun 2014
-
$29.87 M(+1.7%)
Mar 2014
-
$29.38 M(+2.0%)
Dec 2013
$28.82 M(-3.0%)
$28.82 M(+14.1%)
Sep 2013
-
$25.27 M(-10.0%)
Jun 2013
-
$28.08 M(-5.6%)
Dec 2012
$29.73 M(-32.9%)
$29.73 M
Dec 2011
$44.29 M
-

FAQ

  • What is MacroGenics annual total current liabilities?
  • What is the all time high annual current liabilities for MacroGenics?
  • What is MacroGenics annual current liabilities year-on-year change?
  • What is MacroGenics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for MacroGenics?
  • What is MacroGenics quarterly current liabilities year-on-year change?

What is MacroGenics annual total current liabilities?

The current annual current liabilities of MGNX is $56.11 M

What is the all time high annual current liabilities for MacroGenics?

MacroGenics all-time high annual total current liabilities is $74.58 M

What is MacroGenics annual current liabilities year-on-year change?

Over the past year, MGNX annual total current liabilities has changed by +$7.50 M (+15.42%)

What is MacroGenics quarterly total current liabilities?

The current quarterly current liabilities of MGNX is $59.31 M

What is the all time high quarterly current liabilities for MacroGenics?

MacroGenics all-time high quarterly total current liabilities is $74.58 M

What is MacroGenics quarterly current liabilities year-on-year change?

Over the past year, MGNX quarterly total current liabilities has changed by +$3.20 M (+5.71%)